We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

26 hedge funds and large institutions have $7.26M invested in ImmuCell in 2022 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 7 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 5

0.14% less ownership

Funds ownership: 12.67% → 12.53% (-0.14%)

10% less funds holding

Funds holding: 29 → 26 (-3)

15% less capital invested

Capital invested by funds: $8.53M → $7.26M (-$1.27M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
26
Holders Change
-3
Holders Change %
-10.34%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
7
Reduced
5
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Geode Capital Management
Geode Capital Management
Massachusetts
+$119K
2
Morgan Stanley
Morgan Stanley
New York
+$59.6K
3
HighTower Advisors
HighTower Advisors
Illinois
+$24.5K
4
CAM
Cresset Asset Management
Illinois
+$19.7K
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$12.8K

Top Sellers

Rank Fund Capital Flow
1
SRC
Shufro Rose & Co
New York
-$160K
2
Renaissance Technologies
Renaissance Technologies
New York
-$132K
3
UBS Group
UBS Group
Switzerland
-$9.38K
4
Vanguard Group
Vanguard Group
Pennsylvania
-$8.17K
5
TCWM
Total Clarity Wealth Management
Illinois
-$6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.52M -$8.17K -1,000 -0.5%
Renaissance Technologies
2
Renaissance Technologies
New York
$1.03M -$132K -16,201 -11%
BL
3
Bleichroeder LP
New York
$760K – – –
CAM
4
Cresset Asset Management
Illinois
$721K +$19.7K +2,407 +3%
Morgan Stanley
5
Morgan Stanley
New York
$554K +$59.6K +7,300 +11%
SRC
6
Shufro Rose & Co
New York
$467K -$160K -19,629 -24%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$285K +$119K +14,562 +62%
PCM
8
Perritt Capital Management
Illinois
$273K – – –
OMC
9
Overbrook Management Corp
New York
$266K – – –
SFS
10
Strategic Financial Services
New York
$232K – – –
Dimensional Fund Advisors
11
Dimensional Fund Advisors
Texas
$169K +$12.8K +1,563 +7%
HighTower Advisors
12
HighTower Advisors
Illinois
$160K +$24.5K +3,000 +16%
FHA
13
Flagship Harbor Advisors
Massachusetts
$121K – – –
PP
14
Prosperity Planning
Missouri
$120K +$8.17K +1,000 +7%
WE
15
Wealth Effects
Massachusetts
$117K – – –
BlackRock
16
BlackRock
New York
$114K -$3.31K -405 -3%
Northern Trust
17
Northern Trust
Illinois
$95K +$278 +34 +0.3%
MA
18
Minerva Advisors
Pennsylvania
$89K – – –
EFS
19
Essex Financial Services
Connecticut
$82K – – –
HPC
20
HM Payson & Co
Maine
$61K – – –
Bank of America
21
Bank of America
North Carolina
$15K – – –
UBS Group
22
UBS Group
Switzerland
$11K -$9.38K -1,148 -43%
US Bancorp
23
US Bancorp
Minnesota
$4K – – –
GWM
24
Geneos Wealth Management
Colorado
$1K – – –
Northwestern Mutual Wealth Management
25
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
1
2

ICCC Hedge Fund Activity: Q3 2022 in Review

26 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q3 2022, worth a combined $7.26M — down 15% from $8.53M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of ICCC and 0 opened new positions — a net loss of 3 holders — while 5 trimmed existing stakes and 7 added.

The largest buyer was Geode Capital Management, adding an estimated $119K. The largest seller was Shufro Rose & Co, cutting an estimated $160K.

  • 26 institutional investors held ImmuCell (ICCC) as of Q3 2022, down from 29 in Q2 2022.
  • Funds reported $7.26M of ImmuCell stock for Q3 2022, down 15% quarter-over-quarter.
  • 0 funds opened new ImmuCell positions in Q3 2022 and 3 closed out, a net change of -3 holders.
  • The largest ImmuCell buyer in Q3 2022 was Geode Capital Management, an estimated $119K added.
  • The largest ImmuCell seller in Q3 2022 was Shufro Rose & Co, an estimated $160K sold.

Based on aggregated 13F filings for Q3 2022.